The heart of market access: opportunities and challenges for cell and gene therapy development for orphan and prevalent cardiovascular diseases

Our CEO, Faraz Ali, authored an article for Cell & Gene Therapy Insights discussing the opportunities and challenges of developing cell and gene therapies for cardiovascular disease. Cardiovascular diseases, especially orphan indications, are vastly underrepresented in research on regenerative medicine and advanced therapy, but recent advancements suggest an evolving landscape for treating heart disease with cell and gene therapies.

Learn more about these advancements and challenges, as well as Tenaya’s dedication to discovering and developing transformative therapies for cardiovascular disease, in the article.

Read Article